Preliminary efficacy trial of Cymelarsan, a novel trypanocide, in camels naturally infected with Trypanosoma evansi in Kenya

dc.bibliographicCitation.endpage	273	en
dc.bibliographicCitation.stpage	271	en
dc.bibliographicCitation.title	Acta Tropica: Zeitschrift Für Tropenwissenschaften Und Tropenmedizin	en
dc.bibliographicCitation.volume	50	en
dc.contributor.author	Otsyula, M.
dc.contributor.author	Kamar, K.
dc.contributor.author	Mutugi, M.
dc.contributor.author	Njogu, A. R.
dc.contributor.corpauthor	Kenya Trypanosomiasis Research Institute
dc.date.accessioned	2015-08-19T09:13:45Z
dc.date.available	2015-08-19T09:13:45Z
dc.date.issued	1992	en
dc.description.abstract	The novel trypanocide Cymelarsan (Mel Cy. RM11O; Rhone Merieux, France) was shown to have therapeutic activity against Trypanosoma evansi in naturally infected camels in Kenya, at dose rates ranging between 0.2 to 1.2 mg/kg body weight. Systemic and local reactions were mild and transient.	en
dc.identifier.citation	Acta Tropica: Zeitschrift Für Tropenwissenschaften Und Tropenmedizin, 50, p. 271-273	en
dc.identifier.issn	0001-706X	*
dc.identifier.uri	http://localhost:8080/dspace/handle/0/10281
dc.language.iso	en	en
dc.rights.uri	http://creativecommons.org/licenses/by/3.0/	en
dc.subject.agrovoc	Camels	en
dc.subject.agrovoc	morphology	en
dc.subject.agrovoc	Trypanosomiasis	en
dc.subject.agrovoc	Chemotherapy	en
dc.subject.agrovoc	Body weight	en
dc.title	Preliminary efficacy trial of Cymelarsan, a novel trypanocide, in camels naturally infected with Trypanosoma evansi in Kenya	en
dc.type	Journal Contribution	*
dc.type.refereed	Refereed	en
dc.type.specified	Article	en

Files

Now showing 1 - 1 of 1